**Core Concept**
Obsessive-compulsive disorder (OCD) is a chronic mental health condition characterized by recurrent, intrusive thoughts (obsessions) and repetitive behaviors (compulsions). Effective management of OCD requires a multimodal treatment approach, incorporating pharmacological, psychological, and behavioral interventions.

**Why the Correct Answer is Right**
The recommended treatment modalities for OCD include pharmacotherapy with selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine or sertraline, which increase serotonin levels in the brain and reduce symptoms of anxiety and obsessive-compulsive behavior. Behavioral therapy, specifically exposure and response prevention (ERP), is also considered a first-line treatment, helping individuals confront and resist their obsessions and compulsions. Cognitive-behavioral therapy (CBT) and habit reversal training (HRT) are other evidence-based psychological interventions for OCD.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because while benzodiazepines may provide short-term relief from anxiety symptoms, they are not a recommended long-term treatment for OCD due to the risk of dependence and tolerance.
* **Option B:** This option is incorrect because electroconvulsive therapy (ECT) is not a standard treatment for OCD and is typically reserved for severe or treatment-resistant cases of depression, bipolar disorder, or schizophrenia.
* **Option C:** This option is incorrect because while antipsychotics may be used to augment SSRIs in treatment-resistant cases, they are not a primary treatment for OCD.

**Clinical Pearl / High-Yield Fact**
A key aspect of managing OCD is to avoid reinforcing compulsive behaviors, as this can perpetuate the cycle of obsessions and compulsions. The "exposure" component of ERP involves gradually exposing individuals to their feared stimuli, while the "response prevention" component involves resisting the urge to engage in compulsive behaviors.

**Correct Answer: A. Benzodiazepines. Benzodiazepines are not a recommended long-term treatment for obsessive-compulsive disorder.**